Personalized drug therapy with pharmacogenetics - Part 1: Pharmacokinetics

Journal of Psychosocial Nursing and Mental Health Services

Volumn 44, Issue 1, 2006, Pages 13-16

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32144458585     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20060101-04     Document Type: Review

References (12)

1. th ed.). New York: McGraw-Hill.
2. de Leon, J., Susce, M.T., Pan, R.M., Fairchild, M., Koch, W.H., & Wedlund, P.J. (2005). The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuations. Journal of Clinical Psychiatry, 66, 15-27.
3. de Leon, J., Susce, M.T., Pan, R.M., Koch, W.H., & Wedlund, P.J. (2005). Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A4, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. Journal of Clinical Psychopharmacology, 25, 448-456.
4. Epstein, C.J. (2004). Genetic testing: Hope or hype? Genetics in Medicine, 6, 165-172.
5. Jain, K.K. (2005). Applications of AmpliChip CYP450. Molecular Diagnosis, 9, 119-127.
6. Kirchheiner, J., Bertilsson, L., Bruus, H., Wolff, A., Roots, I., & Bauer, M. (2003). Individualized medicine - Implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders. Pharmacopsychiatry, 36(Suppl. 3), S235-S243.
7. Lea, D.H. (2005). Tailoring drug therapy with pharmacogenetics. Nursing2005, 35(4), 22-23.
8. Malhotra, A.K., Murphy, G.M., & Kennedy, J.L. (2004). Pharmacogenetics of psychotropic drug response. American Journal of Psychiatry, 161, 780-796.
9. Ng, C.H., Schweitzer, I., Norman, T., & Easteal, S. (2004). The emerging role of pharmacogenetics: Implications for psychiatry. The Australian and New Zealand Journal of Psychiatry, 38, 483-489.
10. Rau, T., Wohllebenm, G., Wuttke, H., Thuerauf, N., Lunkenheimer, J., Lanczik, M., et al. (2004). CYP2D6 genotype: Impact on adverse effects and nonresponse during treatment with antidepressants - A pilot study. Clinical Pharmacology and Therapeutics, 75, 386-393.
11. rd ed.). Philadelphia: Lippincott Williams & Wilkins.
12. Weinshilboum, R. (2003). Inheritance and drug response. New England Journal of Medicine, 348, 529-537.